Position history for CAPITAL FUND MANAGEMENT S.A.'s holdings in ACADIA PHARMACEUTICALS INC
CAPITAL FUND MANAGEMENT S.A. previously held 0 shares of ACAD (ACADIA PHARMACEUTICALS INC), worth $0 as of 2026-Q1.
Final Value
$0
Final Shares
0
Total Value Change
-$14.9M
Total Shares Change
-916,609
Other major holders of ACAD: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Exited |
| 0 |
-100.0% |
| $0 |
| 0.0% |
| $22.50 |
0 |
| 2025-Q4 | Decreased | 28,540 | -63.1% | $762,303 | 0.0% | $26.70 | 0 |
| 2025-Q3 | Decreased | 77,361 | -38.2% | $1.7M | 0.0% | $21.32 | 0 |
| 2025-Q2 | Decreased | 125,124 | -54.6% | $2.7M | 0.0% | $22.12 | 0 |
| 2025-Q1 | Decreased | 275,474 | -58.3% | $4.6M | 0.0% | $17.07 | 0 |
| 2024-Q4 | Decreased | 660,630 | -15.7% | $12.1M | 0.0% | $16.69 | 0 |
| 2024-Q3 | Decreased | 784,029 | -14.5% | $12.1M | 0.0% | $15.69 | 0 |
| 2024-Q2 | Increased | 916,609 | +31.8% | $14.9M | 0.0% | $16.25 | 36 |